baber/WOPTO huggingface dataset:
Patent NO-922873-D0 (NO)
Inventor: COOPER LEONARD MICHAEL
IPC: B65D71/18
Filed: 1992-07-20
Abstract: Integral retaining means in an open-ended wrap-around carrier for preventing the spaced bottom portions of articles such as tapered tubs from engaging each other and escaping the carrier through the open end. The bottom panel (22) is comprised of inner and outer mechanically connected flaps (24, 26). The outer bottom panel flap (26) contains a retainer flap (32) at each end connected along a fold line (40) overlying the inner edge (68) of an opening (56) in the inner bottom panel flap (24). The retainer flaps (32) extend up into the interior of the carrier through the openings (56) in the inner bottom panel flap (24), and include spaced converging fold lines (50) which create angled side walls (54) for engaging the bottom portions of the articles.
Patent NO-923395-D0 (NO)
Inventor: WEINER HOWARD L
IPC: A61K38/095
Filed: 1992-08-31
Abstract: Disclosed herein are methods to prevent or treat T-cell dependent autoimmune diseases comprising the oral administration of (A) an agent selected from the group consisting of autoantigens, fragments or analogs thereof specific for the autoimmune disease, and (B) a synergist having the property of enhancing the autoimmune disease suppressive activity of the agent, in amounts effective to treat or prevent a T-cell dependent autoimmune disease. Also disclosed are pharmaceutical formulations or dosage forms for use in the methods.
Patent NO-942028-D0 (NO)
Inventor: ANELLI PIERLUCIO
IPC: C07C237/46
Filed: 1994-06-01
Abstract: PCT No. PCT/EP92/02770 Sec. 371 Date Jun. 1, 1994 Sec. 102(e) Date Jun. 1, 1994 PCT Filed Dec. 1, 1992 PCT Pub. No. WO93/12071 PCT Pub. Date Jun. 24, 1993.    <IMAGE>  (I)  wherein R, R', R1, and R1', which are the same or different, are H, C1-C4 alkyl, linear or branched C1-C4 mono- or polyhydroxyalkyl; R2, R2', R3, and R3', which are the same or different, are one of the groups of formula -CH2CH2OH, -CH2CH(OH) CH2OH -CH(CH2OH)CH(OH)CH2OH, -CH2(CHOH)4CH2OH, or -CH(CH2OH)2; and X is one of the groups -CH(OH)-, -CH(CH2OH)-, -C(OH) (CH2OH)-, or -C(CH2OH)2-, are useful as opacifying components for X-ray contrast media.
Patent NO-943780-D0 (NO)
Inventor: MILNE JOHN DE COURCEY
IPC: B62K17/00
Filed: 1994-10-07
Abstract: PCT No. PCT/AU93/00161 Sec. 371 Date Oct. 11, 1994 Sec. 102(e) Date Oct. 11, 1994 PCT Filed Apr. 8, 1993 PCT Pub. No. WO93/20911 PCT Pub. Date Oct. 28, 1993A sports conveyance is disclosed having a frame mounted on a pair of spaced front wheels and also supported by rear wheel means, the front wheels having interconnecting means whereby they may be turned in unison to either side of the longitudinal center line of the conveyance, a board mounted on the frame to support a rider and adapted to be depressed at a respective side of the longitudinal center line of the conveyance, said board being adapted to be disposed in a substantially horizontal position with the front wheels unturned but so connected to the interconnecting means of the front wheels that depression of the board by body weight of the rider at a respective side of the board causes turning of the wheels in unison in the respective direction upon movement of the board.
Patent NO-951213-D0 (NO)
Inventor: PEET NORTON PAUL
IPC: C07H1/00
Filed: 1995-03-29
Abstract: Adenosine analogues which act selectively at adenosine receptors and which act in general as adenosine agonists are disclosed. From (in vitro) studies it is known that specific physiological effects can be distinguished as a result of this selectivity and that adenosine receptor activity (in vitro) correlates with adenosine receptor activity (in vivo). Pharmaceutical preparations of the subject compounds can be prepared on the basis of the selective binding activity of the compounds disclosed herein which will enhance certain physiological effects while minimizing others, such as decreasing blood pressure without decreasing heart rate.
Patent NO-953218-D0 (NO)
Inventor: BEDFORD MICHAEL RICHARD
IPC: A23K1/165
Filed: 1995-08-16
Abstract: The present invention relates to the cloning and high level expression of novel truncated cellulase proteins or derivatives thereof in the filamentous fungus  Trichoderma longibrachiatum . Further aspects of the present invention relate to fungal transformants that express the novel truncated cellulases and derivatives, and expression vectors comprising the DNA gene fragments or variants thereof that code for the truncated cellulases derived from  Trichoderma longibrachiatum  using genetic engineering techniques.
Patent NO-953740-D0 (NO)
Inventor: SCHRICK BERNARD VAN DER
IPC: C08F4/60
Filed: 1995-09-21
Abstract: Olefins are polymerised in contact with a catalyst system contg. (a) a solid catalytic complex based on Mg, a transition metal and a halogen, obtd. by (i) reacting (I) an oxygenated organo-Mg cpd. or a halogenated Mg cpd. with (II) an oxygenated organic cpd. or a halogenated cpd. of a transition metal of Gps. IVB or VB, to give a liq. complex, (ii) precipitating. the complex by means of a cpd. of formula AlRnX3-n, to give a solid catalytic complex, (iii) sepg. the solid complex, and (iv) treating the solid complex with a cpd. of formula AlRnX3-n, and (b) an organic cpd. of a metal of Gps. IA, IIA, IIB, IIIA or IVB. R = hydrocarbo gp.; X = halogen; n = less than 3.
Patent NO-953767-D0 (NO)
Inventor: CARTILIER LOUIS
IPC: A61K9/20
Filed: 1995-09-22
Abstract: The present invention is concerned with the manufacture of solid dosage units (pharmaceutical and others). More specifically, the invention is related to powders of cross-linked amylose, having a specific cross-linking degree for use as tablet binders and disintegrants.
Patent NO-953878-D0 (NO)
Inventor: CASARA PATRICK
IPC: C07F9/6561
Filed: 1995-09-29
Abstract: Novel unsaturated phosphonate derivatives of certain purines or pyrimidines useful as antiviral agents, to methods and intermediates useful for their preparation and to their end-use application as antiviral agents effective against DNA viruses, retroviruses and viruses involved in tumor formation.
Patent NO-954531-D0 (NO)
Inventor: LANSBERRY JOHN B
IPC: A01G23/09
Filed: 1995-11-10
Abstract: An apparatus (10) for severing a standing tree (48) at a trunk portion thereof includes a housing (12) constructed and arranged to be movable to a tree harvesting location. Holding structure (18) is constructed and arranged with respect to the housing (12) to hold a portion of the stem of the tree while the trunk portion thereof is severed. A cutting blade (32) mounted so as to be movable between retracted and extended position with respect to the tree. Impact hammer structure (38) is operatively coupled to the cutting blade (32) such that successive impacts generated by the impact hammer structure (38) on the cutting blade (32) move the cutting blade (32) progressively through the trunk portion of the tree (48). Actuating structure (30) is operatively associated with the cutting blade (32) and constructed and arranged to move the cutting blade (32) between its retracted and extended positions such that when the cutting blade (32) is in an extended position and in engagement with the trunk portion while the holding structure (18) holds the stem of the tree (48), the successive impacts move the cutting blade to sever the standing tree (48).
Patent NO-960863-D0 (NO)
Inventor: NOELLE RANDOLPH J
IPC: A61K35/18
Filed: 1996-03-01
Abstract: Methods of suppressing a humoral immune response to a thymus-dependent (TD) antigen are disclosed. The methods involve administering to a subject a TD antigen with an antagonist of a molecule which mediates contact-dependent helper effector functions. In a preferred embodiment, the antagonist is an antagonist of gp39. Primary and secondary humoral immune responses can be suppressed and suppression is prolonged.
Patent NO-963398-D0 (NO)
Inventor: HOHN ARTHUR
IPC: C10M129/95
Filed: 1996-08-14
Abstract: PCT No. PCT/EP95/00429 Sec. 371 Date Aug. 12, 1996 Sec. 102(e) Date Aug. 12, 1996 PCT Filed Feb. 7, 1995 PCT Pub. No. WO95/21904 PCT Pub. Date Aug. 17, 1995Carboxylic esters of the formula IR1-CO-O-R2 I,where R1 is an aliphatic, straight-chain or branched hydrocarbon radical having alkyl side chains and a number average molecular weight of from 250 to 5000 and R2 is a straight-chain or branched hydrocarbon radical of 1 to 30 carbon atoms or a radical of the formula II    <IMAGE>  II  where R3, R4, R5 and R6, independently of one another, are each hyrogen, branched or straight-chain alkyl, an aromatic radical or an araliphatic radical which may also contain heteroatoms, R7 and R8, independently of one another, are each branched or straight-chain alkyl or an aromatic or araliphatic radical which may also contain heteroatoms, X is O, S, NR9 or PR9, where R9 is an aliphatic or aromatic radical, n and m, independently of one another, are each from 2 to 20, and x is from 0 to 30, are used as fuel additives or lubricant additives, and fuel compositions or lubricant compositions contain these additives. Carboxylic acids or carboxylic esters are prepared by reacting polymers having at least 30 carbon atoms and at least one carbon-carbon double bond with carbon monoxide and water or an alcohol.
Patent NO-964831-D0 (NO)
Inventor: BEAUQUIN JEAN-LOUIS
IPC: F16L59/05
Filed: 1996-11-14
Abstract: A thermal isolation system of a pipe (10) (figure 1) is claimed. It consists of a sleeve consisting of an aerogel which surrounds at least part of the length of the pipe. The aerogel is made up of a precursor consisting of tetraethylorthosilicate. The thermal isolation process consists of several steps: (a) fabricating of a liquid gel from a precursor and a liquid; (b) substituting the liquid phase by a more volatile solvent; (c) eliminating the solvent in the gel in order to form the aerogel.
Patent NO-975115-D0 (NO)
Inventor: SIGAUD ALAIN
IPC: G06F21/41
Filed: 1997-11-06
Abstract: A process for protecting accesses to at least one server (30) is characterized in that it makes it possible to protect accesses originating from user stations (2) whose destination is at least one application server through a network (42) using a multisession, multiport telecommunication protocol, said process consisting of a step for the systematic establishment of a parallel security session between the user station (2) and a security processor (1) interposed between the user station to be protected during application sessions and the server or servers (30) to be protected and a step for the cyclic initiation of security sessions.
Patent NO-982870-D0 (NO)
Inventor: BIGGE CHRISTOPHER F
IPC: C07D211/28
Filed: 1998-06-19
Abstract: PCT No. PCT/US96/20872 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23216 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs are selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described.
Patent GB-0000360-D0 (GB)
Title: Canine health diet
IPC: A23K1/175
Filed: 2000-01-07
Abstract: The present invention provides comestibles and related aspects for use in maintaining canine urinary tract health. In particular the comestibles and related aspects are useful in preventing the initial occurrence of canine calcium oxalate urolithiasis. The present invention also provides a comestible, which when fed to a small breed canine animal results in a urine specific gravity of 1.025 or below, for use in preventing the initial occurrence of calcium oxalate urolithiasis in the canine animal and related aspects. The comestible includes the following ingredients in the ranges indicated, for use in preventing the initial occurrence of calcium oxalate urolithiasis in a canine animal and related aspects:
Patent GB-0214114-D0 (GB)
Title: Threshing machinery concave arrangements
IPC: A01F12/28
Filed: 2002-06-20
Abstract: A concave arrangement is disclosed for a threshing machine such as a combine harvester (10). The arrangement includes a concave (30) having a moveable rear portion 48 that is adapted to vary the break-over angle presented to straw passing downstream. A flap member (54) is provided that moves jointly with the moveable rear portion (48) and ensures that a gap (G) between the moveable portion (48) and a later processing stage such as a beater apparatus is kept substantially closed. Variation of the break-over angle influences the length of the straw leaving the threshing machine and the loading of the further separation and cleaning mechanisms. <IMAGE>
Patent GB-0513376-D0 (GB)
Title: Novel galactooligosaccharide composition and the preparation thereof
IPC: A61K31/702
Filed: 2004-06-30
Abstract: Novel strains of Bifidobacterium hifidum capable of producing a novel galactosidase enzyme activity that converts lactose to a novel mixture of galactooligosaccharides. The mixture of oligosaccharidcs may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
Patent GB-0604089-D0 (GB)
Title: Method and apparatus for extraction of arthropod gland
Filed: 2006-03-01
Abstract: An apparatus and method for the extraction of material from glands of arthropods. The apparatus comprises a container in which at least part of the glands are placed and a buffer solution at least partially immersing the glands. Gland material is collected in the material collection area of container. In use the material is released from glands into the buffer solution and sedimented at the bottom of the container. The method comprises: a first step of removing from a body of the arthropod the gland containing at least partially the material; a second step of making an opening in an epithelium of the gland; and a third step of placing the gland in a container at least partially immersed in a buffer solution such that the materials exit the glands and sediments in the material collection area of the container.
Patent GB-0604892-D0 (GB)
Title: Acoustically coupled resonators and method of making the same
Filed: 2006-03-10
Abstract: An apparatus includes a substrate with a cavity and a two-stage resonator filter fabricated over the cavity. The two-stage resonator filter includes a first stage and a second stage. The first stage includes a first resonator and a second resonator, the second resonator acoustically coupled to the first resonator. The second stage includes a third resonator and a fourth resonator, the fourth resonator acoustically coupled to the third resonator. The second resonator and the third resonators are electrically coupled. A decoupling layer couples the first resonator and the second resonator. The decoupling layer extends between the third resonator and the fourth resonator. The first resonator and the fourth resonator are above the substrate. The decoupling layer is above the first resonator and the fourth resonator. The second resonator and the third resonators are above the decoupling layer.
Patent GB-0608561-D0 (GB)
Title: Surgical apparatus
Filed: 2006-04-29
Abstract: A surgical apparatus (10) comprises a support member (12), and first and second mounting arrangements (26, 28) for mounting respective first and second retractors (22, 24) mounted on the support member. The mounting arrangements are mounted on the support member, and at least the first mounting arrangement is movable towards and away from the second mounting arrangement.
Patent GB-0615215-D0 (GB)
Title: A Filter Assembly
Filed: 2006-08-01
Abstract: A filter assembly for use in a cleaning appliance has filter portion and a rim surrounding the filter portion. The rim is deformable so as to be capable of sealing against a part of an appliance in which the filter assembly is located. The rim is arranged to include a locating member adapted to prevent incorrect orientation of the filter assembly in an appliance housing. The rim is flexible and capable of being manipulated and flexed by a user during a process of locating the filter assembly in an appliance.
Patent GB-0718417-D0 (GB)
Title: Intramedullary rod instrument
Filed: 2007-09-21
Abstract: A femoral instrument for use in the intramedullary canal is described and includes an intramedullary rod having a tip at a free end. A body is attached to the intramedullary rod and has a face with a bone abutting portion. A centralizer mechanism is located within the rod and is operable to deploy and retract a plurality of members to engage and disengage an inner surface of the intramedullary canal. The length of the intramedullary rod from the tip to the face of the body is less than 30 cm. The instrument can also include an angular adjustment mechanism. The angular adjustment mechanism can have a plurality of formations and can be rotated about the longitudinal axis of the intramedullary rod to present at least a one of the formations to abut a portion of the body to define the relative angle between the body and the intramedullary rod.
Patent GB-0815795-D0 (GB)
Title: Network system for vessel instruments
Filed: 2008-08-29
Abstract: A network system where vessel instruments including sensors are connected through a communication network is provided. The sensors generate the same type of navigation data. The system includes a first network for realizing one-to-many communication, a first group instruments connected with each other through the first network, and a second group instruments connected to the first network with a different protocol from the first network. The first group instrument is an input/output gate between the second group instruments and the first network. At least one of the first group instruments has a server function. The first group instruments obtain identification information and types of navigation data of the second group instruments using the first group instruments as the gates, and the server-function instrument obtains identification information and types of navigation data of the instruments. The server function instrument selects one of the sensors generating the same type of navigation data, and outputs a sharing instruction of the data of the selected sensor, through the first network. The first group instrument provides the sharing instruction to the second group instruments using the first group instrument as the gate.
Patent GB-8610305-D0 (GB)
Title: Inspection apparatus
IPC: G01N21/89
Filed: 1986-04-28
Abstract: An inspection apparatus for inspecting, for example, sheet material, in which a beam of radiation l2 is scanned across a sheet l3 by means of a first facet 4l of a rotating mirror drum 22. Scattered radiation from the sheet is received by a second facet 46 and 2 is passed to a photodetector 49 for analysis.
Patent GB-8722684-D0 (GB)
Title: Mixing of farinaceous material
IPC: A21C1/14
Filed: 1987-09-26
Abstract: A mixing element (18) for the mixing of farinaceous material, is arranged to rotate at different speeds during the development of the material. The power developed by the motor is arranged to be constant throughout as the whole of mixing process and the speed of the rotating element is decreased as the resistance to its motion, provided by the developing farinaceous material, increases. This characteristic, which is required for minimum power wastage, may be effected by the sensing of the resistance provided by the developing material.
Patent GB-8727489-D0 (GB)
Title: Detoxification of pertussis toxin
IPC: C07K19/00
Filed: 1987-11-24
Abstract: A new method is described for the preparation of a safe, immunogenic and efficacious vaccine for protection against the disease pertussis. In development of this vaccine, specific functional sites of pertussis toxin have been identified, and using this information, defined mutant holotoxins have been produced by site directed mutagenesis of the toxin gene. A number of these toxin analogues are detoxified, retain an immunodominant S1 epitope, are immunogenic and are protective in the standard pertussis vaccine potency test in mice. Mutant strains of B. pertussis are described from which the native toxin operon has been deleted and replaced by a mutant gene which expresses the mutant holotoxins. The native TOX operon of a specific B. pertussis strain has been isolated, sequenced and cloned into plasmid DNA.
Patent GB-8909492-D0 (GB)
Title: Instant food product
IPC: A23G9/52
Filed: 1989-04-26
Abstract: Food product comprising an edible gas hydrate clathrate which on addition of water, milk or skim-milk provides a milk shake. A method of preparing a milk shake by mixing a fluid constituent of a usual milk shake composition with the balance of said composition also comprising an edible gas hydrate clathrate.
Patent GB-8925797-D0 (GB)
Title: Compositions
IPC: A61K31/445
Filed: 1989-11-15
Abstract: An aqueous liquid formulation which comprises a compound of the formula : <CHEM> wherein the symbols define certain groups, particularly the compound 17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methyl vinyl]-23, 25-dimethoxy-13,19,21,27-tetramethyl-11-28-dioxa-4-azatricyclo[22.3.2. 0<4,9</ SP>]octacos-18-ene-2,3,10,16-tetraone, and process for its preparation.
Patent GB-9202615-D0 (GB)
Title: Pharmaceutical product for the treatment of sepsis
IPC: A61P31/04
Filed: 1992-02-07
Abstract: An antibody to tumour necrosis factor- alpha  (anti-TNF) and an antibody to bacterial lipopolysaccharide (anti-LPS) used together in a neutropenic rat model of sepsis are shown to enhance survival of the rats relative to either antibody used alone. Pharmaceutical products including each of the components are therefore of utility in therapy of sepsis. The anti-LPS antibody included may be specific for the O-specific chain of a particular bacterial lipopolysaccharide (serotype specific antibody) but preferably recognises the core glycolipid of lipopolysaccharide.
Patent GB-9224956-D0 (GB)
Title: Improvements relating to allergen testing & apparatus
IPC: G01N33/50
Filed: 1992-11-28
Abstract: The invention relates to the use of a secretor variant cell-line expressing the alpha moiety of human IgE binding protein to determine the allergic status of a given individual. Moreover, the cell-line is also used to provide an assay system for determining the allergenicity of substances and for subsequently providing therapeutic compositions which render said substances ineffective. In addition, the invention also relates to the use of said cell-line to determine the IgE independent irritancy of substances and compositions effective for attenuating the effects of said substances.
Patent GB-9401689-D0 (GB)
Title: Diagnosis and treatment of endocarditis
IPC: C12P21/08
Filed: 1994-01-28
Abstract: The present invention provides a purified bacterial protein expressed during infection due to streptococci or enterococci and isolated from human sera, together with immunogenic fragments, analogs, inhibitors, antibodies and antigenic fragments specific thereto. Also provided is a DNA sequence coding for a bacterial protein or an immunogenic fragment or an analogue thereof expressed during infection due to Streptococci or Enterococci, together with homologues thereof, together with vectors, probes and inhibitors therefor. Also provided is fibronectin or an immunogenic fragment thereof or an analogue thereof or an antibody thereto or an anigen binding fragment thereof when used in a method of treatment or diagnosis of the human or animal body for infection due to Streptococci or Enterococci. Also provided are antibodies specific to HSP 90 or immunogenic fragments or analogues thereof for use in a method of diagnosis or treatment of the human or animal body of infection due to steptococci or enterococci due to any one of the group of S.oralis, S.gordonii, S.sanguis.